U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06930209) titled 'Histological Analysis of CelluJuve(R) Injections in the Brachium' on March 21.
Brief Summary: Single-center, exploratory study assessing the safety and histological presentation of CelluJuve(R) injected into the brachium of healthy volunteers
Study Start Date: March 28
Study Type: INTERVENTIONAL
Condition:
Healthy Male and Female Subjects
Intervention:
DEVICE: CelluJuve(R)
CelluJuve(R) injected into upper brachium
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Spiderwort Biotechnologies Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....